Home > Cashflow Statement > CONCORD DRUGS

CONCORD DRUGS
Cash Flow from Financing Activities

    Back to Cashflow Statement
CONCORD DRUGS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for CONCORD DRUGS
Please provide your vote to see the results

CONCORD DRUGS Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022
Cash Flow from Financing Activities ₹-1.43 Cr₹0.28 Cr₹0.62 Cr₹1.68 Cr

What is the latest Cash Flow from Financing Activities ratio of CONCORD DRUGS ?

The latest Cash Flow from Financing Activities ratio of CONCORD DRUGS is ₹-1.43 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Financing Activities
Mar2025₹-1.43 Cr
Mar2024₹0.28 Cr
Mar2023₹0.62 Cr
Mar2022₹1.68 Cr

How is Cash Flow from Financing Activities of CONCORD DRUGS Trending?

Years Cash Flow from Financing Activities % Change
Mar2025 ₹-1.43 Cr
Negative
Mar2024 ₹0.28 Cr
-54.65
Mar2023 ₹0.62 Cr
-62.84
Mar2022 ₹1.68 Cr -

Compare Cash Flow from Financing Activities of peers of CONCORD DRUGS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CONCORD DRUGS ₹99.4 Cr -5.5% 5.2% 12.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹440,398.0 Cr -0.4% -3.3% 15.5% Stock Analytics
DIVIS LABORATORIES ₹248,664.0 Cr 0.4% 9.9% 55.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹182,738.0 Cr -3.4% -4.2% 37.1% Stock Analytics
CIPLA ₹110,794.0 Cr 0.5% -3.2% -12.8% Stock Analytics
DR REDDYS LABORATORIES ₹97,749.4 Cr 0.9% 0% -11% Stock Analytics


CONCORD DRUGS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
CONCORD DRUGS

-5.5%

5.2%

12.3%

SENSEX

-0.8%

-3.8%

-8.9%


You may also like the below Video Courses